Quote | Immunovant Inc. (NASDAQ:IMVT)
Last: | $27.75 |
---|---|
Change Percent: | 2.05% |
Open: | $28.21 |
Close: | $27.75 |
High: | $28.52 |
Low: | $27.44 |
Volume: | 1,265,630 |
Last Trade Date Time: | 04/25/2024 03:00:00 am |
News | Immunovant Inc. (NASDAQ:IMVT)
2024-04-23 09:30:00 ET Summary Baron is an asset management firm focused on delivering growth equity investment solutions known for a long-term, fundamental, active approach to growth investing. In the quarter ended March 31, 2024, Baron Health Care Fund advanced 8.92% compared wi...
2024-04-04 02:12:07 ET Summary Immunovant's IMVT-1402 shows promise for at-home autoimmune treatment, with a differentiated subcutaneous delivery. Phase 1 data indicate significant IgG reductions without major side effects, advancing toward registrational trials. Financial hea...
Message Board Posts | Immunovant Inc. (NASDAQ:IMVT)
Subject | By | Source | When |
---|---|---|---|
* * $IMVT Video Chart 06-01-2021 * * | ClayTrader | investorshub | 06/01/2021 9:46:11 PM |
* * $IMVT Video Chart 03-08-2021 * * | ClayTrader | investorshub | 03/08/2021 9:26:55 PM |
Why is it going down?? | Roadtojourney | investorshub | 03/08/2021 3:53:37 PM |
Immunovant shares are trading higher after Roivant Sciences | crudeoil24 | investorshub | 03/08/2021 2:26:58 PM |
Immunovant, Inc., formerly Health Sciences Acquisitions Corp, is | crudeoil24 | investorshub | 03/08/2021 2:08:04 PM |
News, Short Squeeze, Breakout and More Instantly...
Immunovant Inc. Company Name:
IMVT Stock Symbol:
NASDAQ Market:
2024-04-02 14:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Composition of matter patent issued with coverage until June 2043 Patent also includes methods of use and methods of manufacturing claims NEW YO...
Composition of matter patent issued with coverage until June 2043 Patent also includes methods of use and methods of manufacturing claims NEW YORK, March 12, 2024 (GLOBE NEWSWIRE) -- Immunovant, Inc. (Nasdaq: IMVT) , a clinical-stage immunology company dedicated to enabling no...